Results 71 to 80 of about 47,792 (97)

Pregabalin Population Pharmacokinetic and Exposure-Response Analyses for Focal Onset Seizures in Children (4-16 years) and Adults, to Support Dose Recommendations in Children. [PDF]

Clin Pharmacol Ther, 2021
Chan PLS, Marshall SF, McFadyen L, Liu J.   +3 more
europepmc   +1 more source

Safety, Tolerability, and Efficacy of Adjunctive Brivaracetam in Japanese and Chinese Patients with Focal-Onset Seizures: Interim Analysis of a Phase 3 Open-Label Extension Trial. [PDF]

Adv Ther
Fujimoto A, Qin B, Bourikas D, Dickson N, Moseley B, Sano T, Soma T, Sun W, Watanabe J, Zhou D, Inoue Y.   +10 more
europepmc   +1 more source

Temporal Profile of Treatment-Emergent Adverse Events in Adult Asian Patients with Focal-Onset Seizures During Adjunctive Brivaracetam Treatment: Post Hoc Analysis of a Phase 3, Randomized Trial. [PDF]

Adv Ther
Usui N, Zhou D, Qin B, Tiamkao S, Cabral-Lim L, Lim KS, Lim SH, Tsai JJ, Watanabe J, Sun W, Dickson N, Moseley B, Bourikas D, Inoue Y.   +13 more
europepmc   +1 more source

Real-world experience with direct brain-responsive neurostimulation for focal onset seizures. [PDF]

Epilepsia, 2020
Razavi B, Rao VR, Lin C, Bujarski KA, Patra SE, Burdette DE, Geller EB, Brown MM, Johnson EA, Drees C, Chang EF, Greenwood JE, Heck CN, Jobst BC, Gwinn RP, Warner NM, Halpern CH.   +16 more
europepmc   +1 more source

Cenobamate as an Early Adjunctive Treatment in Drug-Resistant Focal-Onset Seizures: An Observational Cohort Study. [PDF]

CNS Drugs
Winter Y, Abou Dargham R, Patiño Tobón S, Groppa S, Fuest S.   +4 more
europepmc   +1 more source

Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal-onset seizures with newly diagnosed or currently untreated recurrent epilepsy: A post hoc analysis of the open-label Study 342 (FREEDOM). [PDF]

Epilepsia Open, 2022
Husni RE, Ngo LY, Senokuchi H, Patten A, Hiramatsu H, Watanabe K, Yamamoto T.   +6 more
europepmc   +1 more source

Effectiveness During 12-Month Adjunctive Brivaracetam Treatment in Patients with Focal-Onset Seizures in a Real-Life Setting: A Prospective, Observational Study in Europe. [PDF]

Neurol Ther
Steinhoff BJ, Christensen J, Doherty CP, Majoie M, Schulz AL, Brock F, Bourikas D, Leunikava I, Kelemen A, Rubio-Nazabal E.   +9 more
europepmc   +1 more source

Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis. [PDF]

CNS Drugs, 2020
Lattanzi S, Trinka E, Zaccara G, Striano P, Del Giovane C, Silvestrini M, Brigo F.   +6 more
europepmc   +1 more source

Health-Related Quality of Life and Cognitive Performance During 12-Month Adjunctive Brivaracetam Treatment in Patients with Focal-Onset Seizures: A Prospective, Observational Study in Europe. [PDF]

Neurol Ther
Rubio-Nazabal E, Majoie M, Schulz AL, Brock F, Leunikava I, Bourikas D, Steinhoff BJ.   +6 more
europepmc   +1 more source

Effect of Cenobamate on Cognition in Patients with Drug-Resistant Epilepsy with Focal Onset Seizures: An Exploratory Study. [PDF]

CNS Drugs
Serrano-Castro PJ, Ramírez-García T, Cabezudo-Garcia P, Garcia-Martin G, De La Parra J.   +4 more
europepmc   +1 more source